Azasulfurylpeptide Modulation of CD36-Mediated Inflammation Without Effect on Neovascularization
- Supplementary File 1:
PDF-Document (PDF, 22268 KiB)
Turcotte, S.; Mellal, K.; Chingle, R.; Mulumba, M.; Omri, S.; Dif-Yaiche, L.; Chemtob, S.; Ong, H.; Lubell, W.D. Azasulfurylpeptide Modulation of CD36-Mediated Inflammation Without Effect on Neovascularization. Biomedicines 2018, 6, 98. https://doi.org/10.3390/biomedicines6040098
Turcotte S, Mellal K, Chingle R, Mulumba M, Omri S, Dif-Yaiche L, Chemtob S, Ong H, Lubell WD. Azasulfurylpeptide Modulation of CD36-Mediated Inflammation Without Effect on Neovascularization. Biomedicines. 2018; 6(4):98. https://doi.org/10.3390/biomedicines6040098
Chicago/Turabian StyleTurcotte, Stéphane, Katia Mellal, Ramesh Chingle, Mukandila Mulumba, Samy Omri, Lylia Dif-Yaiche, Sylvain Chemtob, Huy Ong, and William D. Lubell. 2018. "Azasulfurylpeptide Modulation of CD36-Mediated Inflammation Without Effect on Neovascularization" Biomedicines 6, no. 4: 98. https://doi.org/10.3390/biomedicines6040098